20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a…
| Price | $0.48 |
|---|---|
| Market cap | $5.87M |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Exchange | NASDAQ |
| 52-week range | 0.4-50 |
| Beta | 1.54 |
Explore AIDX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.